| Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ... science 310 (5748), 644-648, 2005 | 4907 | 2005 |
| Delineation of prognostic biomarkers in prostate cancer SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ... Nature 412 (6849), 822-826, 2001 | 2148 | 2001 |
| Integrative molecular concept modeling of prostate cancer progression SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ... Nature genetics 39 (1), 41-51, 2007 | 1092 | 2007 |
| Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ... Nature 448 (7153), 595-599, 2007 | 1008 | 2007 |
| Role of the TMPRSS2-ERG gene fusion in prostate cancer SA Tomlins, B Laxman, S Varambally, X Cao, J Yu, BE Helgeson, Q Cao, ... Neoplasia 10 (2), 177-IN9, 2008 | 914 | 2008 |
| Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ... Cancer cell 8 (5), 393-406, 2005 | 902 | 2005 |
| Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition S Shangary, D Qin, D McEachern, M Liu, RS Miller, S Qiu, ... Proceedings of the National Academy of Sciences 105 (10), 3933-3938, 2008 | 848 | 2008 |
| Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ... Cancer research 64 (24), 9209-9216, 2004 | 747 | 2004 |
| TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer SA Tomlins, R Mehra, DR Rhodes, LR Smith, D Roulston, BE Helgeson, ... Cancer research 66 (7), 3396-3400, 2006 | 588 | 2006 |
| Prostate-specific membrane antigen expression as a predictor of prostate cancer progression S Perner, MD Hofer, R Kim, RB Shah, H Li, P Möller, RE Hautmann, ... Human pathology 38 (5), 696-701, 2007 | 576 | 2007 |
| A polycomb repression signature in metastatic prostate cancer predicts cancer outcome J Yu, J Yu, DR Rhodes, SA Tomlins, X Cao, G Chen, R Mehra, X Wang, ... Cancer research 67 (22), 10657-10663, 2007 | 418 | 2007 |
| The role of SPINK1 in ETS rearrangement-negative prostate cancers SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ... Cancer cell 13 (6), 519-528, 2008 | 400 | 2008 |
| Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer R Mehra, SA Tomlins, R Shen, O Nadeem, L Wang, JT Wei, KJ Pienta, ... Modern Pathology 20 (5), 538-544, 2007 | 378 | 2007 |
| Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer R Mehra, SA Tomlins, J Yu, X Cao, L Wang, A Menon, MA Rubin, ... Cancer research 68 (10), 3584-3590, 2008 | 339 | 2008 |
| Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity S Gobbo, JN Eble, DJ Grignon, G Martignoni, GT MacLennan, RB Shah, ... The American journal of surgical pathology 32 (8), 1239-1245, 2008 | 336 | 2008 |
| Noninvasive detection of TMPRSS2: ERG fusion transcripts in the urine of men with prostate cancer B Laxman, SA Tomlins, R Mehra, DS Morris, L Wang, BE Helgeson, ... Neoplasia 8 (10), 885-888, 2006 | 325 | 2006 |
| Comparison of the basal cell-specific markers, 34βE12 and p63, in the diagnosis of prostate cancer RB Shah, M Zhou, M LeBlanc, M Snyder, MA Rubin The American journal of surgical pathology 26 (9), 1161-1168, 2002 | 311 | 2002 |
| Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States JM Mosquera, R Mehra, MM Regan, S Perner, EM Genega, G Bueti, ... Clinical cancer research 15 (14), 4706-4711, 2009 | 294 | 2009 |
| Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications JM Mosquera, S Perner, EM Genega, M Sanda, MD Hofer, KD Mertz, ... Clinical Cancer Research 14 (11), 3380-3385, 2008 | 290 | 2008 |
| Integrative genomics analysis reveals silencing of β-adrenergic signaling by polycomb in prostate cancer J Yu, Q Cao, R Mehra, B Laxman, J Yu, SA Tomlins, CJ Creighton, ... Cancer cell 12 (5), 419-431, 2007 | 282 | 2007 |
Mark A RubinProfessor & Director Department for BioMedical Research, University of Bernایمیل تأیید شده در dbmr.unibe.ch
